T2 Biosystems Share Price Today
(NASDAQ: TTOO)

Name: T2 Biosystems Share Price Today (NASDAQ: TTOO) - T2 Biosystems Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

T2 Biosystems share price is $0.13 & ₹11.29 as on 12 Feb 2025, 2.30 'hrs' IST

$0.13

▲

-0.06

(-31.07%)

Market is closed - opens 8 PM, 12 Feb 2025

View live T2 Biosystems share price in Dollar and Rupees. Guide to invest in T2 Biosystems stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in T2 Biosystems, along with analyst recommendations, forecasts, and comprehensive financials.

T2 Biosystems share price movements

Today's Low: $0.11
Today's High: $0.15
$0.13
14.08%
Downside
Day's Volatility :27.89%
Upside
16.07%
52 Weeks Low: $0.13
52 Weeks High: $6.95
$0.13
0.0%
Downside
52 Weeks Volatility :98.13%
Upside
98.13%

T2 Biosystems (TTOO) Returns

Period	T2 Biosystems Inc	Index (Russel 2000)
3 Months	-75.55%	0.0%
6 Months	-96.35%	0.0%
1 Year	-97.85%	0.0%
3 Years	-99.99%	-12.9%

T2 Biosystems (TTOO) Key Statistics

in dollars & INR

Previous Close	$0.1944
Open	$0.11
Today's High	$0.1549
Today's Low	$0.1117
Market Capitalization	$10.5M
Today's Volume	$3.2M
52 Week High	$6.95
52 Week Low	$0.1117
Revenue TTM	$7.2M
EBITDA	$-42.1M
Earnings Per Share (EPS)	$-0.03
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-622.14%

How to invest in T2 Biosystems Stock (TTOO) from India?

It is very easy for Indian residents to invest directly in T2 Biosystems from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the T2 Biosystems stock in both Indian Rupees (INR) and US Dollars (USD). Search for T2 Biosystems or TTOO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of T2 Biosystems or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of T2 Biosystems shares which would translate to 6.679 fractional shares of T2 Biosystems as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like T2 Biosystems, in just a few clicks!

Returns in T2 Biosystems (TTOO) for Indian investors in Rupees

The T2 Biosystems stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

T2 Biosystems investment value today

Current value as on today

₹6,673

Returns

₹93,327

(-93.33%)

Returns from T2 Biosystems Stock

₹97,917 (-97.92%)

Dollar Returns

₹4,590 (+4.59%)

Indian investors sentiment towards T2 Biosystems (TTOO)

-46%

Period: Jan 12, 2025 to Feb 11, 2025. Change in 30 Days versus previous period

Search interest for T2 Biosystems Stock from India on INDmoney has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in T2 Biosystems

Armistice Capital, LLC
4.98%
Vanguard Group Inc
1.39%
Geode Capital Management, LLC
0.32%
BlackRock Inc
0.27%
State Street Corp
0.23%
Susquehanna International Group, LLP
0.16%

Analyst Recommendation on T2 Biosystems

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for T2 Biosystems(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on T2 Biosystems Stock (TTOO)

What analysts predicted

Upside of 3746.15%

Target:

$5.00

Current:

$0.13

Insights on T2 Biosystems Stock (Ticker Symbol: TTOO)

Price Movement
In the last 7 days, TTOO stock has moved down by -39.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.95M → 1.98M (in $), with an average increase of 1.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -8.96M → -10.11M (in $), with an average decrease of 12.9% per quarter
TTOO vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 7.1% return, outperforming this stock by 105.0%
TTOO vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 3.3% return, outperforming this stock by 103.3%
Price to Sales
ForTTOO every $1 of sales, investors are willing to pay $0.1, whereas for Agilent Technologies Inc., the investors are paying $6.4 for every $1 of sales.

TTOO T2 Biosystems Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.5M	↑ 125.03%
Net Income	$-51.2M	↓ 18.06%
Net Profit Margin	-487.17%	↑ 850.76%

	FY19	Y/Y Change
Revenue	$8.3M	↓ 20.62%
Net Income	$-63.1M	↑ 23.38%
Net Profit Margin	-757.19%	↓ 270.02%

	FY20	Y/Y Change
Revenue	$18.1M	↑ 117.52%
Net Income	$-49.2M	↓ 22.03%
Net Profit Margin	-271.42%	↑ 485.77%

	FY21	Y/Y Change
Revenue	$28.1M	↑ 54.76%
Net Income	$-53.5M	↑ 8.71%
Net Profit Margin	-190.66%	↑ 80.76%

	FY22	Y/Y Change
Revenue	$22.3M	↓ 20.5%
Net Income	$-63.4M	↑ 18.46%
Net Profit Margin	-284.11%	↓ 93.45%

	FY23	Y/Y Change
Revenue	$7.2M	↓ 67.75%
Net Income	$-50.1M	↓ 20.98%
Net Profit Margin	-696.19%	↓ 412.08%

	Q2 FY23	Q/Q Change
Revenue	$2.0M	↓ 5.49%
Net Income	$-6.3M	↓ 68.33%
Net Profit Margin	-323.17%	↑ 641.17%

	Q3 FY23	Q/Q Change
Revenue	$1.5M	↓ 25.05%
Net Income	$-15.4M	↑ 143.03%
Net Profit Margin	-1.0K%	↓ 724.72%

	Q4 FY23	Q/Q Change
Revenue	$1.7M	↑ 14.06%
Net Income	$-10.3M	↓ 32.97%
Net Profit Margin	-615.84%	↑ 432.05%

	Q1 FY24	Q/Q Change
Revenue	$2.1M	↑ 22.75%
Net Income	$-13.5M	↑ 30.89%
Net Profit Margin	-656.67%	↓ 40.83%

	Q2 FY24	Q/Q Change
Revenue	$2.0M	↓ 5.29%
Net Income	$-9.0M	↓ 33.77%
Net Profit Margin	-459.17%	↑ 197.5%

	Q3 FY24	Q/Q Change
Revenue	$2.0M	↑ 1.69%
Net Income	$-10.1M	↑ 12.88%
Net Profit Margin	-509.67%	↓ 50.5%

	FY18	Y/Y Change
Profit	$-4.9M	↓ 33.39%

	FY19	Y/Y Change
Profit	$-8.4M	↑ 71.86%

	FY20	Y/Y Change
Profit	$-3.2M	↓ 62.62%

	FY21	Y/Y Change
Profit	$7.4M	↓ 333.49%

	FY22	Y/Y Change
Profit	$1.2M	↓ 84.15%

	FY23	Y/Y Change
Profit	$-8.2M	↓ 800.69%

	Q2 FY23	Q/Q Change
Profit	$-2.9M	↑ 51.54%

	Q3 FY23	Q/Q Change
Profit	$-2.5M	↓ 15.56%

	Q4 FY23	Q/Q Change
Profit	$-895.0K	↓ 63.51%

	Q1 FY24	Q/Q Change
Profit	$-2.1M	↑ 139.22%

	Q2 FY24	Q/Q Change
Profit	$-741.0K	↓ 65.39%

	Q3 FY24	Q/Q Change
Profit	$-2.1M	↑ 185.56%

	FY18	Y/Y Change
Operating Cash Flow	$-40.1M	↓ 15.88%
Investing Cash Flow	$-593.0K	↓ 76.05%
Financing Cash Flow	$49.7M	↑ 168.34%

	FY19	Y/Y Change
Operating Cash Flow	$-45.4M	↑ 13.01%
Investing Cash Flow	$-761.0K	↑ 28.33%
Financing Cash Flow	$6.4M	↓ 87.21%

	FY20	Y/Y Change
Operating Cash Flow	$-43.2M	↓ 4.73%
Investing Cash Flow	$-36.3M	↑ 4664.91%
Financing Cash Flow	$85.6M	↑ 1248.14%

	FY21	Y/Y Change
Operating Cash Flow	$-38.9M	↓ 10.05%
Investing Cash Flow	$24.8M	↓ 168.37%
Financing Cash Flow	$20.5M	↓ 76.01%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.4M	↓ 4.27%
Investing Cash Flow	$-33.0K	↑ 0.0%
Financing Cash Flow	$18.4M	↑ 55.19%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-13.4M	↑ 8.12%
Investing Cash Flow	$-13.0K	↓ 60.61%
Financing Cash Flow	$21.6M	↑ 17.7%

T2 Biosystems Technicals Summary

Sell

Neutral

Buy

T2 Biosystems is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

T2 Biosystems (TTOO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
T2 Biosystems Inc	-58.12%	-96.35%	-97.85%	-99.99%	-100.0%
Agilent Technologies Inc.	-0.14%	4.2%	9.24%	4.84%	65.17%
Idexx Laboratories, Inc.	9.73%	-2.36%	-16.54%	-8.27%	60.59%
Thermo Fisher Scientific, Inc.	-1.85%	-9.45%	1.23%	-2.84%	60.74%
Danaher Corp.	-15.95%	-24.79%	-16.52%	-25.74%	21.49%
Iqvia Holdings Inc.	-1.83%	-14.95%	-6.68%	-16.26%	22.26%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
T2 Biosystems Inc	0.02	NA	0.0	0.0	-6.22	-0.9	NA	-6.91
Agilent Technologies Inc.	32.81	32.81	2.45	5.57	0.25	0.08	0.01	20.53
Idexx Laboratories, Inc.	43.09	43.09	4.59	11.97	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	34.6	34.6	2.22	23.33	0.13	0.05	0.0	128.08
Danaher Corp.	39.06	39.06	3.89	7.67	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.82	26.82	1.1	11.9	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
T2 Biosystems Inc	Sell	$10.5M	-100.0%	0.02	0.0%
Agilent Technologies Inc.	Buy	$41.0B	65.17%	32.81	21.75%
Idexx Laboratories, Inc.	Buy	$38.1B	60.59%	43.09	22.53%
Thermo Fisher Scientific, Inc.	Buy	$211.5B	60.74%	34.6	14.48%
Danaher Corp.	Buy	$146.3B	21.49%	39.06	16.39%
Iqvia Holdings Inc.	Buy	$35.4B	22.26%	26.82	9.17%

About T2 Biosystems

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Organization	T2 Biosystems
Employees	113
CEO	Mr. John J. Sperzel III, B.Sc.
Industry	Health Technology

Management People of T2 Biosystems

Name	Title
Mr. John J. Sperzel III, B.Sc.	President, CEO & Chairman
Mr. John M. Sprague CPA	Chief Financial Officer
Mr. Michael Terrence Gibbs Esq.	Senior VP, General Counsel & Company Secretary
Ms. Kelley J. Morgan	Chief People Officer
Mr. Brett A. Giffin	Chief Commercial Officer
Dr. Roger Smith Ph.D.	Senior Vice President of Science Research & Development

Important FAQs about investing in TTOO Stock from India :

What is T2 Biosystems share price today?

T2 Biosystems share price today stands at $0.13, Open: $0.11 ; Previous Close: $0.19 ; High: $0.15 ; Low: $0.11 ; 52 Week High: $6.95 ; 52 Week Low: $0.13.

The stock opens at $0.11, after a previous close of $0.19. The stock reached a daily high of $0.15 and a low of $0.11, with a 52-week high of $6.95 and a 52-week low of $0.13.

Can Indians buy T2 Biosystems shares?

Yes, Indians can invest in the T2 Biosystems (TTOO) from India.

With INDmoney, you can buy T2 Biosystems at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy T2 Biosystems at zero transaction cost.

How can I buy T2 Biosystems shares from India?

It is very easy to buy T2 Biosystems from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of T2 Biosystems (TTOO) be purchased?

Yes, you can buy fractional shares of T2 Biosystems with INDmoney app.

What are the documents required to start investing in T2 Biosystems stocks?

To start investing in T2 Biosystems, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.